Clinical Trial Update: REward Processing And Citalopram Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trial update for a study investigating reward processing and citalopram in individuals with anhedonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: University of Oxford | Conditions: Anhedonia | Phase 1, Phase 2 | Status: UNKNOWN